Innovation Pharmaceuticals Inc (IPIX)

[BonelessCat]

According to Leo:
“Estimates vary as to the market size (in dollars) of an effective OM treatment, for HNC-only patients, across major markets (U.S., Europe and Japan), ranging between $500 million and $1.5 billion on an annual basis (sources: GlobalData; Redington Inc., pdf). One company in the OM space projects the worldwide OM market opportunity to be as high as $2.6 billion annually.”

Using the lowest estimate, $500 million globally would generate $50 to $75 million upfront plus benchmark payments to NDA and market of another several hundred million. Striking a deal would cause a run to over a 1 dollar and perhaps 2. A .30 to .50 price reflects an end of p2 report that includes fast-track elements with rolling review. A deal puts the SP 4 to 8 times higher.